Definitions

11 works

Journal

1. International Agency for Research on Cancer

   National Cancer Institute

   OtherScience, Research, and MedicineDefinitions20206 citations

   ABIABI:AkademIndex/openalex/2026.other.000055

2. Flanvotumab

   National Cancer Institute

   OtherCancer Immunotherapy and BiomarkersDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000087

3. Anetumab

   National Cancer Institute

   OtherMyeloproliferative Neoplasms: Diagnosis and TreatmentDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000089

4. Narnatumab

   National Cancer Institute

   OtherCancer Immunotherapy and BiomarkersDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000090

5. Catumaxomab

   National Cancer Institute

   OtherMultiple Myeloma Research and TreatmentsDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000091

6. Ombitasvir

   National Cancer Institute

   OtherSystemic Lupus Erythematosus ResearchDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000092

7. Gerbil Fibrosarcoma

   National Cancer Institute

   OtherSarcoma Diagnosis and TreatmentDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000093

8. Anetumab Ravtansine

   National Cancer Institute

   OtherMultiple Myeloma Research and TreatmentsDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000094

9. Ustilago maydis

   National Cancer Institute

   OtherPlant Disease Resistance and GeneticsDefinitions20200 citations

   ABIABI:AkademIndex/openalex/2020.other.000095

10. Seribantumab

    National Cancer Institute

    OtherNeutrophil, Myeloperoxidase and Oxidative MechanismsDefinitions20200 citations

    ABIABI:AkademIndex/openalex/2020.other.000098

11. Gerbil Fibroma

    National Cancer Institute

    OtherShoulder and Clavicle InjuriesDefinitions20200 citations

    ABIABI:AkademIndex/openalex/2020.other.000102